Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...